SOPH

Conviction 80TechnologyScan · Thu, Sep 24, 2026

SOPHiA GENETICS SA (SOPH) closed at $8.29 (+2.60%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 56, RS Rating 96, -7.1% from its 52-week high, +77.5% year to date. Sector: Technology · Health Information Services.

SOPH$8.29+2.60%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 709K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

SOPHiA GENETICS SAHealth Information Serviceswww.sophiagenetics.com ↗

Price8.29

Change+2.60%

Gap+1.05%

Rel volume0.72×

Avg volume699.02K

Avg $ vol5.71M

SMA 208.16

SMA 507.43

SMA 2005.59

Price vs 50+11.57%

Price vs 200+48.20%

MA stackbullish

50/200 cross—

Supertrendup · 7.30

RSI (14)56

MACD hist-0.05

MACD cross—

Stoch %K / %D65 / 53

ADX (14)29

+DI / −DI24 / 13

RSI divergence—

MACD divergence—

ATR %5.24%

ADR %5.46%

52w high8.92

52w low3.43

From 52w high-7.06%

Above 52w low+141.69%

New 52w highNo

SqueezeOff

Bollinger width14.46%

%B0.61

Donchian pos52.41%

Donchian high8.98

Donchian low7.53

AVWAP (52w high)8.15

vs AVWAP high+1.68%

AVWAP (52w low)6.25

vs AVWAP low+32.61%

OBV trendUp

Chaikin MF (20)0.24

Today vs 20d0.72×

Avg vol (14d)709K

Avg vol (20d)699.02K

Avg $ vol (20d)5.71M

Market cap567.75M

RS Rating96 / 99

RS 3m (vs SPY)+41.20%

RS 6m (vs SPY)+58.82%

RS line new highNo

Trend template8/8

Technical rank87.8

1 week-2.81%

1 month-4.16%

3 months+45.69%

6 months+75.64%

1 year+109.34%

YTD+77.52%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target10.00

Target upside20.63%

Analyst ratingBuy

Institutional43.28%

Ent. value567.75M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryHealth Information Services

ExchangeNasdaq

Shares out68.49M

Employees415

ListedFri, Jul 23, 2021

Free float44M

Float %61.4%

Short interest1.1M

Days to cover1.9d

Short volume45.9%

Squeeze score19 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.26 vs −$0.15

Last surprise-73.3% miss

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank87.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance8.84

Support7.39

Days since event—

Candle confirm—

Congress activity

Disclosed STOCK Act trades in SOPH

All disclosures →

No recent disclosed trades by Congress in SOPH. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SOPH · open-market 9 sells

Insider	Side	Shares	Value	Traded	Filed
Xu Zhenyu Chief Scientific Officer · Ordinary Shares · 2026-08-27	Sell	10K	$89K	2026-08-27	2026-08-31
Menu Philippe Chief Medical Officer · Ordinary Shares · 2026-08-25	Sell	5K	$43K	2026-08-25	2026-08-26
HIBBS KATHY L Director · Ordinary Shares · 2026-08-25	Sell	6.25K	$54K	2026-08-25	2026-08-26
Verma Abhimanyu Chief Technology Officer · Ordinary Shares · 2026-08-24	Sell	5K	$44K	2026-08-24	2026-08-26
Verma Abhimanyu Chief Technology Officer · Ordinary Shares · 2026-08-19	Sell	5K	$41K	2026-08-19	2026-08-26
Xu Zhenyu Chief Scientific Officer · Ordinary Shares · 2026-08-21	Sell	5.41K	$45K	2026-08-21	2026-08-21
Xu Zhenyu Chief Scientific Officer · Ordinary Shares · 2026-08-20	Sell	4.59K	$39K	2026-08-20	2026-08-21
Valente Manuela Chief People Officer · Ordinary Shares · 2026-08-19	Exercise	10K	$32K	2026-08-19	2026-08-21
Xu Zhenyu Chief Scientific Officer · Ordinary Shares · 2026-08-19	Sell	10K	$79K	2026-08-19	2026-08-21
Valente Manuela Chief People Officer · Ordinary Shares · 2026-08-19	Sell	10K	$79K	2026-08-19	2026-08-21

SEC filings

EDGAR filings in SOPH · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.